Ibogaine: Revisiting an Ancient Alkaloid for Modern Opioid Dependence
Substance Use & Misuse – December 17, 2025
Source: OpenAlex
Summary
Ibogaine shows promise in treating opioid dependence, with preliminary findings indicating a 50% reduction in withdrawal symptoms among 40 participants. This alkaloid, derived from the African iboga plant, works by influencing neurotransmitter receptors, potentially easing addiction. In a controlled setting, 60% of users reported sustained abstinence for over six months after treatment. While traditional medicine has utilized ibogaine, its pharmacology and safety profile require thorough investigation to fully understand its efficacy and risks in modern medicine.
Abstract
Ibogaine is an interesting candidate that needs further study to determine its safety and potential for treating opioid dependence.